Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice

被引:16
作者
Baz, Mariana
Abed, Yacine
Nehme, Benjamin
Boivin, Guy [1 ]
机构
[1] CHUL, CHUQ, Res Ctr Infect Dis, Ste Foy, PQ G1V 4G2, Canada
关键词
A-315675; INFECTION;
D O I
10.1128/AAC.01276-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The new oral neuraminidase (NA) inhibitor A-322278 was evaluated in mice infected with influenza A/H1N1 wild-type virus or the oseltamivir-resistant (H274Y mutant) virus. A-322278 decreased mortality rates and lung virus titers significantly more than oseltamivir in mice infected with the NA H274Y mutant when therapy was started 4 h before or even 48 h after infection.
引用
收藏
页码:791 / 793
页数:3
相关论文
共 13 条
[1]  
Abed Y, 2004, ANTIVIR THER, V9, P577
[2]   Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes [J].
Abed, Yacine ;
Nehme, Benjamin ;
Baz, Mariana ;
Boivin, Guy .
ANTIVIRAL RESEARCH, 2008, 77 (02) :163-166
[3]   Treatment of respiratory virus infections [J].
Abed, Yacine ;
Boivin, Guy .
ANTIVIRAL RESEARCH, 2006, 70 (02) :1-16
[4]   Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an Immunocompromised child [J].
Baz, Mariana ;
Abed, Yacine ;
McDonald, Jane ;
Boivin, Guy .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (12) :1555-1561
[5]   Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].
de Jong, MD ;
Thanh, TT ;
Khanh, TH ;
Hien, VM ;
Smith, GJD ;
Chau, NV ;
Cam, BV ;
Qui, PT ;
Ha, DQ ;
Guan, Y ;
Peiris, JSM ;
Hien, TT ;
Farrar, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672
[6]   Enantioselective synthesis of antiinfluenza compound A-315675 [J].
DeGoey, DA ;
Chen, HJ ;
Flosi, WJ ;
Grampovnik, DJ ;
Yeung, CM ;
Klein, LL ;
Kempf, DJ .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (16) :5445-5453
[7]   Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection [J].
Ison, MG ;
Mishin, VP ;
Braciale, TJ ;
Hayden, FG ;
Gubareva, LV .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (06) :765-772
[8]   Recovery of drug-resistant influenza virus from immunocompromised patients: A case series [J].
Ison, MG ;
Gubareva, LV ;
Atmar, RL ;
Treanor, J ;
Hayden, FG .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (06) :760-764
[9]   In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication [J].
Kati, WM ;
Montgomery, D ;
Carrick, R ;
Gubareva, L ;
Maring, C ;
McDaniel, K ;
Steffy, K ;
Molla, A ;
Hayden, F ;
Kempf, D ;
Kohlbrenner, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1014-1021
[10]  
Lackenby A., 2008, Eurosurveillance, V13, P8026